We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$11.8B
AUM Growth
-$12M
Cap. Flow
-$798M
Cap. Flow %
-6.77%
Top 10 Hldgs %
34.79%
Holding
664
New
200
Increased
87
Reduced
122
Closed
155

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$116M
2
ADBE icon
Adobe
ADBE
+$102M
3
CVS icon
CVS Health
CVS
+$92M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$67M
5
MSFT icon
Microsoft
MSFT
+$66.7M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$148M
2
VST icon
Vistra
VST
+$144M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
4
GM icon
General Motors
GM
+$72.6M
5
HON icon
Honeywell
HON
+$70.6M

Sector Composition

Rank Sector Weight
1 Healthcare 11.7%
2 Technology 5.56%
3 Consumer Discretionary 2.87%
4 Financials 2.43%
5 Energy 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXK
551
Endeavour Silver
EXK
$3.03B
-24,250
Closed -$47.8K
FDMT icon
552
4D Molecular Therapeutics
FDMT
$582M
-52,828
Closed -$1.07M
FDX icon
553
PUT
FedEx
FDX
$76.9B
-7,400
Closed -$1.87M
FRO icon
554
Frontline
FRO
$8.56B
-29,425
Closed -$590K
GD icon
555
General Dynamics
GD
$107B
-44,472
Closed -$11.5M
GE icon
556
PUT
GE Aerospace
GE
$380B
-214,514
Closed -$21.9M
GILD icon
557
Gilead Sciences
GILD
$165B
-108,096
Closed -$8.76M
GILD icon
558
PUT
Gilead Sciences
GILD
$165B
-270,000
Closed -$21.9M
GIS icon
559
CALL
General Mills
GIS
$19.9B
-175,000
Closed -$11.4M
GIS icon
560
General Mills
GIS
$19.9B
-68
Closed -$4.43K
GNW icon
561
Genworth Financial
GNW
$3.75B
-10,054
Closed -$67.2K
HR icon
562
Healthcare Realty
HR
$6.73B
-22,048
Closed -$380K
HYG icon
563
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
-48,557
Closed -$3.75M
IBM icon
564
IBM
IBM
$223B
-35,127
Closed -$5.75M
IBM icon
565
PUT
IBM
IBM
$223B
-100,000
Closed -$16.4M
IMA
566
ImageneBio Inc
IMA
$64.9M
-31,051
Closed -$734K
IOVA icon
567
Iovance Biotherapeutics
IOVA
$2.9B
-637,742
Closed -$5.18M
ITOS
568
DELISTED
iTeos Therapeutics
ITOS
-50,121
Closed -$549K
IVR icon
569
Invesco Mortgage Capital
IVR
$795M
-14,000
Closed -$124K
JNJ icon
570
CALL
Johnson & Johnson
JNJ
$631B
-63,200
Closed -$9.91M
JNJ icon
571
PUT
Johnson & Johnson
JNJ
$631B
-63,200
Closed -$9.91M
JRVR icon
572
James River Group Holdings
JRVR
$210M
-12,694
Closed -$117K
KO icon
573
Coca-Cola
KO
$374B
-148,108
Closed -$8.9M
KRE icon
574
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
-31,700
Closed -$1.66M
LCID icon
575
Lucid Motors
LCID
$2.6B
-13,402
Closed -$564K

Similar funds

Laurion Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Laurion Capital Management held 664 positions worth $11.8B, down 0.1% from $11.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Laurion Capital Management withdrew a net $798M in Q1 2024, closing 155 positions and reducing 122 holdings. Its most notable exit was Vistra, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.8% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Laurion Capital Management opened a new position in Adobe worth $90.1M.

  • Laurion Capital Management's largest Q1 2024 buy was Adobe: 178,555 shares worth $90.1M.
  • Laurion Capital Management added most to Apple in Q1 2024, an estimated $116M increase.
  • Laurion Capital Management's biggest Q1 2024 reduction was Kenvue, cutting an estimated $148M.
  • Laurion Capital Management fully exited Vistra in Q1 2024, selling an estimated $144M.
  • Laurion Capital Management's ten largest holdings make up 35% of its $11.8B portfolio in Q1 2024.
  • Laurion Capital Management opened 200 new positions and closed 155 in Q1 2024.
  • Laurion Capital Management's portfolio value fell 0.1% quarter-over-quarter to $11.8B.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.